TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

517 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

138 studies on the map

Exercise Neuroprotection in Parkinson's Disease — Gait and Balance Laboratory, 217 Bigelow Health Sciences Building, UNLV, Las VegasA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants — Emory University, AtlantaParkinson's Foundation PD GENEration Genetic Registry — University of Alabama Birmingham, BirminghamStatin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study — Stanford University, StanfordDaily Amino Acid Supplementation for People With Parkinson's Disease — University of Connecticut, StorrsA Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease — Cedars Sinai Medical Center, Los AngelesMindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF — VA Boston, BostonAutologous Stem Cell Transplant for Crohn's Disease — Icahn School of Medicine at Mount Sinai, New YorkTURN-IT FOG: Improving Turning and Freezing of Gait in People With PD — Arizona State University, TempePhase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments — Domino's Farms, Ann ArborEffects of RAS on Gait in PD Patients With DBS — Johns Hopkins School of Medicine, BaltimoreVirtual tES Device Treatment for Parkinson's Disease Motor Symptoms — U LLC Headquarters, ClevelandA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease — Peak Gastroenterology Associates - Colorado Springs-Site Number: 8400039, Colorado SpringsSleep-specific DBS Therapy in Parkinson's Disease — University Of Minnesota, MinneapolisA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis — Del Sol Research Management, LLC - Site Number: 8400012, TucsonCortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing — Oregon Health and Science University, PortlandCOMPARE - Pediatric Inflammatory Bowel Disease (PIBD) — University of North Carolina at Chapel Hill, Chapel HillEffects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease — The Regenesis Project, Santa MonicaImpact of Morning Light Therapy in IBD — Mount Sinai Hospital, New YorkTargeted Motor Learning to Improve Gait for Individuals With Parkinson Disease — University of North Carolina at Chapel Hill, Chapel HillClinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease — Phoenix Children's Hospital, PhoenixColonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder — Digestive Disease Associates, BranfordAI Platform for Fatigue and Depression Detection — Indiana University, IndianapolisClinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis — Johns Hopkins, BaltimoreChanges in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs — University of Texas at El Paso Doctor of Physical Therapy and Movement Sciences Building, El PasoThe Weight of Cardiovascular Disease — Mayo Clinic in Rochester, RochesterThe Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease — Brigham and Women's Hospital, BostonAdapting and Testing a Novel Digital Health Tool (PREVENT) to Improve Health Behavior Counseling and Cardiovascular Health in Rural Primary Care Clinics — Washington University in St. Louis, St LouisA Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease — Banner Sun Health Research Institute, Sun CityAssessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD — Connecticut Children's Medical Center, HartfordEffects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) Patients — NYIT College of Osteopathic Medicine, Old WestburyA Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Autologous Peripheral Nerve Tissue Into the Brain for Non-motor or Motor Symptoms in Patients With Parkinson's Disease Undergoing DBS Surgery — University of Kentucky, LexingtonModerate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease — Atlanta VA Medical and Rehab Center, Decatur, GA, DecaturApathy in Parkinson Disease TMS Study — UNC-Chapel Hill, Cassidy Lab, Chapel HillA Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors — UConn Health, FarmingtonCharacterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease. — University of Minnesota, MinneapolisSegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease — University of Texas Southwestern Medical Center, DallasA Study of Buntanetap in Participants With PD — University of Alabama at Birmingham, BirminghamA Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) — Digestive Health Specialsits, DothanHyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC) — University of Alabama Medicine, BirminghamPET Imaging Evaluation of [11C]SY08 — MGH, CharlestownPregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation — Icahn School of Medicine at Mount Sinai, New YorkA Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease — Phoenix Children's Hospital, PhoenixA US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications — Banner Alzheimer's Institute (BAI)-Phoenix, PhoenixImpact of a Biophoton Therapy on Patients With Brain Disorders — Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001, ButlerFeasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease — Richmond VA Medical Center, Richmond, VA, RichmondStudy of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis — GI Alliance, Sun CityEvaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies — Institute for Neurodegenerative Disorders and XingImaging, LLC, New HavenStudy of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention — Tulane University, New OrleansStriatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation — University of Michigan, Ann ArborAn Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis — Erick H. Alayo Medical Corporation - Gastro SB Clinic, Chula VistaA Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease — Banner Sun Health Research Institute, Sun CityA Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD) — Woodholme Gastroenterology Associates, Glen BurnieFeasibility Test of Action Planning in Pediatric IBD — University of North Carolina-Chapel Hill School of Medicine, Chapel HillA Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease — Barrow Neurological Institute, PhoenixWatchWell: Simple and Practical Strategies to Reduce the Negative Health Impact of Sedentary Screen Time — Arizona State University, TempeSocial & QoL Behaviors in Parkinson's Disease — The George Washington University, Washington D.C.Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease — University of California San Francisco, San FranciscoGenetics and Aerobic Exercise to Slow Parkinson's Disease Trial — The Cleveland Clinic, ClevelandSpeech Learning and Speech Production in Parkinson's Disease — State University of New York at Buffalo, BuffaloImpact of Prebiotics in Ulcerative Colitis — UCLA, Los AngelesEffect of Statins on Crohn's Disease — Stanford University, StanfordSpinal Cord Stimulation for Parkinson's Disease Rehabilitation — Frazier Rehab Institute, LouisvilleAcute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes — University of Texas Health Science Center at San Antonio, San AntonioOptimizing Deep Brain Stimulation to Improve Visuomotor Function in Parkinson's Disease — Louis Stokes VA Medical Center, Cleveland, OH, ClevelandAutologous Stem Cell Transplantation for Crohn's Disease — UPMC Prebyterian- Adult Gastroenterology, PittsburghSafety and Tolerability of Patterned Stimulation for DBS in the Home Setting — University of Florida, GainesvilleNew Heart Imaging Techniques to Evaluate Possible Heart Disease — National Institutes of Health Clinical Center, BethesdaEndurance Exercise & Virtual Reality for Optimizing Cortical Excitability and Neuroplasticity in PD — UT Health San Antonio- Dept. of Physical Therapy, San AntonioStereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor — Vanderbilt University Medical Center, NashvilleRegistry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry — Neurology and Pain Specialty, Aliso ViejoModifiable Variables in Parkinsonism (MVP) — Bastyr University, KenmoreLY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis — Valleywise Health Medical Center, PhoenixImpact of the Enhanced Recovery After Surgery System for Colorectal Surgery — University of Arkansas for Medical Sciences, Little RockColonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis — Oregon Health & Science University, PortlandReverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial — Children's Hospital of Philadelphia, PhiladelphiaAn Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab — National Institutes of Health Clinical Center, BethesdaA Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease — UCSD Medical Center, La JollaStudy of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis — Massachusetts General Hospital, BostonValue of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer. — Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, CharlestownEffects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease — Movement Disorders Laboratory, MinneapolisHome Hospital for Suddenly Ill Adults — Brigham and Women's Hospital, BostonSocial Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease — Icahn School of Medicine at Mount Sinai, New YorkThe Influence of a Fasting Mimicking Diet on Ulcerative Colitis — Stanford University, Palo AltoTesting the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease — Weill Cornell Medicine, New YorkCereset Research Exploratory Study — Wake Forest University Health Scienc\ess, Winston-SalemOpen-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease — Invicro (dba Perceptive), New HavenStudy of DISC-0974-201 in Participants With IBD and Anemia — One of a Kind Clinical Research Center, LLC, ScottsdaleAdaptive DBS to Offset STN Dysregulation During Exercise in PD — University of Colorado, AuroraPre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease — NYU Langone Health, New YorkUnderstanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis — University of California San Diego, San DiegoSelenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies — Northwestern University, ChicagoA Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis — Investigational Site Number: 8400009, EscondidoGlobus Pallidus Stimulation to Treat Insomnia — Mayo Clinic in Florida, JacksonvilleA Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease — Mayo Clinic in Arizona - Scottsdale, ScottsdaleFiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF) — University of Michigan, Ann ArborImproving Coronary Vascular Health in Women — Massachusetts General Hospital, BostonAmitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease — University of Michigan, Ann ArborA Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease — Phoenix Children's Hospital /ID# 255766, PhoenixStudy in Parkinson Disease of Exercise — University of Alabama at Birmingham, BirminghamStimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD — University of Alabama at Birmingham, BirminghamTreatment of Moderate to Severe Refractory Crohn's Disease — Mayo Clinic Arizona, ScottsdalePercept Transitions in FOG and PD — University of Minnesota, Movement Disorders Lab, MinneapolisA Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis — BAMC, HoustonVirtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients — University of Michigan, Ann ArborFermented Food-Supplemented Diet in Ulcerative Colitis — Stanford University, Palo AltoA Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis — Phoenix Children's Hospital /ID# 273015, PhoenixRemote Haptic Rehabilitation for Parkinson's Disease — Virginia Tech, BlacksburgA Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002) — Clinnova Research ( Site 1042), AnaheimZymfentra (Infliximab-dyyb) REal World Cohort STudy — Yale University School of Medicine, New HavenEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Pinnacle Research Group, LLC, AnnistonOnline Motor Control in People With Parkinson's Disease — University of Delaware, NewarkImaging Depression in Parkinson's Disease — Yale University, New HavenZesty Exercise System for Therapeutic Engagement — Emory University, 57 Executive Park S NE, Ste 200, AtlantaA Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease — Collaborative Neuroscience Network - CNS, Los AlamitosStaged Kidney Transplantation During Combined Heart/Kidney Transplantation — Cedars-Sinai Medical Center, Los AngelesKetamine for Veterans With Parkinson's Disease — San Francisco VA Medical Center, San Francisco, CA, San FranciscoTriage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility — Brooklyn Clinical Research, BrooklynAn Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis — Onyx Clinical Research - Site Number: 8400021, PeoriaSAD Study in Patients With Parkinson's Disease and Motor Fluctuations — Rocky Mountain Clinical Research, EnglewoodNYSCF Scientific Discovery Biobank — New York Stem Cell Foundation Research Institute, New YorkTreatment of UC With Novel Therapeutics — Brigham and Women's Hospital, Chestnut HillStudy of Novel Therapeutics for Acute Remedy of Colitis — Brigham and Women's Hospital, Chestnut HillVirtual Cycling Environments for Persons With Parkinson Disease — School of Health Professions, NewarkALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool — Med-Care Research Corp, MiamiA Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis — Children's Healthcare of Atlanta, AtlantaSotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease — Stanford University Medical Center, StanfordEarly Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging) — Institute for Neurodegenerative Disorders, New HavenStudy to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications — Evidera, a PPD Business Unit /ID# 238688, MorrisvilleAdapting rHIRE and Sleep Monitoring in Parkinson's Disease — University of Colorado Anschutz Medical Campus, AuroraA Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — Digestive Health Specialists of the Southeast, DothanSPYRAL GEMINI Pilot Study — Stanford Hospital and Clinics, StanfordAquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation — University of Michigan, Ann ArborEvaluation of a Decision Aid for Deep Brain Stimulation Surgery for Parkinson's Disease — University of Colorado Anschutz, AuroraPsilocybin Therapy for Depression in Parkinson's Disease — University of California, San Francisco, San FranciscoEfficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease — IMC Gulf Coast Gastroenterology, PC, FairhopeA Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease — United Medical Doctors, MurrietaAdaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2) — University of Nebraska Medical Center, Omaha

Showing the 150 nearest — narrow your filters for fewer, closer studies.